SCHEMBL6134080

SCHEMBL6134080

COCCn1nc(-c2sc(C(=O)NC(C)C)nc2-c2ccccc2)ccc1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.53
HSD17B10 Q99714 4/20 0.43
TSHR P16473 2/20 0.42
CASP1 P29466 2/20 0.42
ALOX15 P16050 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 1/20 0.41
HTT P42858 2/20 0.40
ALDH1A1 P00352 2/20 0.39
CYP1A2 P05177 2/20 0.39
GLA P06280 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
CASP7 P55210 1/20 0.39
HIF1A Q16665 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
CDK4 P11802 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6133496 0.91 KDM4E (0.54) KDM4EHSD17B10TSHRCASP1ALOX15
SCHEMBL6133356 0.89 KDM4E (0.51) KDM4EHSD17B10TSHRCASP1ALOX15
SCHEMBL6133402 0.88 KDM4E (0.41) KDM4EHSD17B10TSHRCASP1ALOX15
SCHEMBL6134162 0.87 MEN1 (0.51) KDM4ETSHRCASP1ALOX15MEN1
SCHEMBL6828616 0.86 USP2 (0.43) KDM4EHSD17B10MEN1KMT2AHTT
SCHEMBL6133470 0.86 ALDH1A1 (0.47) KDM4EHSD17B10TSHRCASP1ALOX15
SCHEMBL6133469 0.86 HTT (0.47) KDM4EHSD17B10MEN1KMT2APOLB
SCHEMBL6133400 0.86 KDM4E (0.48) KDM4EHSD17B10TSHRCASP1ALOX15
SCHEMBL6133540 0.84 KMT2A (0.51) KDM4EHSD17B10TSHRALOX15MEN1
SCHEMBL6133813 0.83 ALOX15 (0.46) KDM4ETSHRCASP1ALOX15MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR KDM4E 3814/4885HSD17B10 391/4885TSHR 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.